首页/数据集/Proportion of antipsychotic polypharmacy compared with monotherapy (n = 1116).

Proportion of antipsychotic polypharmacy compared with monotherapy (n = 1116).

Figshare2016-10-21 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Proportion_of_antipsychotic_polypharmacy_compared_with_monotherapy_n_1116_/4051314 数据链接链接失效反馈

官方服务：

资源简介：

Proportion of antipsychotic polypharmacy compared with monotherapy (n = 1116).

应用场景：

创建时间：

2016-10-21

结直肠癌治疗

药物联合疗法

Limited agents are optional after standard first and second line treatment for mCRC. Only Regorafenib and Fruquintinib are approved in China. PFS of these targeted drugs are not very long. Pemetrexed

NIAID Data Ecosystem50

癌症精准医疗

药物联合疗法

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is a leading cause of cancer related mortality worldwide. HCC occurs typically from a background of chronic liver disease,

NIAID Data Ecosystem20

Genistein in Treatment of Metastatic Colorectal Cancer

转移性结直肠癌治疗

药物联合疗法

Colorectal neoplasms are the third most common malignancies in the United States. Patients with metastatic (stage IV) colorectal cancer have a median life expectancy of 2 years. The response rates to

NIAID Data Ecosystem20

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer

胰腺癌治疗

药物联合疗法

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer

integrated proteome resources30

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

结直肠癌治疗

药物联合疗法

This is a non-randomized study in patients who have received prior 5-FU therapy for colorectal cancer. The objective of this trial is to establish a maximum tolerated dose of ALIMTA and irinotecan giv

NIAID Data Ecosystem20

Proportion of antipsychotic polypharmacy compared with monotherapy (n = 1116).

资源简介：

相关数据集